Investigation of Brain Nitrogen in Partial Ornithine Transcarbamylase Deficiency (OTCD) Using 1 H MRS, DTI, and fMRI
Sponsor: Andrea Gropman
A observational or N/A phase clinical study on Ornithine Transcarbamylase Deficiency, this trial is completed. The trial is conducted by Andrea Gropman and has accumulated 9 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Apr 2024 [monthly]
Completed
-
Mar 2020 — Jan 2021 [monthly]
Completed
▶ Show 4 earlier versions
-
Jun 2018 — Mar 2020 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Completed NA
Status: Terminated → Completed
-
Jan 2017 — May 2017 [monthly]
Terminated NA
First recorded
Sep 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Andrea Gropman
- Children's National Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.